Do statins reduce hepatitis C RNA titers during routine clinical use?

Figure 4 Lack of correlation between serum cholesterol and HCV RNA viral load, but apparent association with hypertriglyceridemia. Linear correlation of log HCV RNA titers (IU/mL) and serum total cholesterol (mg/dL) in Group A (A), Group B (B), and Group C (C). P-values obtained by Spearman correlation; D: Log HCV RNA titers for patients with serum triglycerides greater than or below 250 mg/dL excluding patients on gemfibrozil or niacin (> 250 mg/dL: median 6 760 000 IU/mL vs < 250 mg/dL: median 3 130 000 IU/mL, P = 0.042); E: Log HCV RNA titers for patients with or without exposure to niacin, excluding patients on gemfibrozil (exposed: median 835 000 IU/mL vs unexposed: median 3 350 000 IU/mL, P = 0.041); F: Log HCV RNA titer among patients with hypertriglyceridemia, excluding gemfibrozil therapy, with and without exposure to niacin shows lower HCV RNA viral load in niacin-treated patients (niacin-exposed: median 835 000 IU/mL vs unexposed: median 6 760 000 IU/mL, P = 0.013).